The handover matters as much as the sign-up.

A change of provider creates two conversations: an administrative handover and a clinical treatment plan. Keep both visible. A lower fee may be attractive, but before committing, establish who will review your records, who will answer clinical questions during the transition, and what the receiving service needs before making its own prescribing decision.

What continuing-treatment research can tell us

SURMOUNT-4 first gave participants tirzepatide for 36 weeks, then randomized 670 adults without diabetes to continue treatment or switch to placebo. Over the following 52 weeks, weight changed by a further −5.5% in the continued-treatment group and +14.0% in the placebo group, measured from randomization. This withdrawal design found substantial regain after treatment withdrawal in that study population. It was not a study of transferring between telehealth providers. Read SURMOUNT-4 in JAMA.

The STEP 1 extension followed a subset after semaglutide and the study’s lifestyle intervention ended. Its exploratory analysis included 327 participants; after a year off treatment, the semaglutide group had regained about two-thirds of its prior weight loss. Because the extension also stopped the lifestyle intervention and studied a subset, it cannot isolate every reason for the subsequent change. Read the STEP 1 extension.

What those findings do not decide

Neither paper tells a reader when to change medication, restart after a gap, or choose a dose. Neither establishes that every person will regain the same amount. Discuss continuing treatment, tolerability and the implications of any interruption with the clinician responsible for your care. An administrative checklist can organize that discussion; it cannot replace it.

As a consumer, ask what happens after the introductory period and after the initial goal-setting conversation. NIDDK explains that treatment duration depends on benefit and side effects. The practical implication for comparing services is to ask about ongoing care before paying, rather than assuming a short enrollment describes the entire course. See NIDDK’s discussion of treatment duration.

Build a handover folder

Ask the receiving clinic which records it requires and how to send them securely. Useful questions concern the existing treatment record, prior authorization documents, pharmacy details and requested laboratory reports. Do not upload those records to a comparison website. Confirm that a named service will receive and review them; having an account alone is not the same as a completed clinical review.

Put the billing questions in writing as well. When does the new membership begin? What cancels the old renewal? Does ending membership affect access to records or pending orders? Which team owns unresolved insurance paperwork? These are questions to establish with the two services, not promises that a particular provider offers a seamless transfer.

Leave the next conversation with clear responsibilities

Our switching checklist creates questions around the practical needs you select. Print it, add the answers during calls, and keep the confirmation messages. The useful outcome is a clear point of contact and an agreed next administrative step. Medication timing and treatment changes belong in a separate, individual discussion with your prescriber.